Skip to content

Capecitabine EP Impurity A

Capecitabine EP Impurity A

Product Description
CAT No.
ALN-C003002
CAS No.
66335-38-4
Mol. F.
C9H12FN3O4
Mol. Wt.
245.2
Stock
Please Inquire
RFQ
Chemical Name : 4-Amino-1-(5-deoxy-β-D-ribofuranosyl)-5-fluoropyrimidin-2(1H)-one (as per EP); 5′-Deoxy-5-fluorocytidine (as per USP)
Smiles : C[C@@H]1[C@H]([C@H]([C@H](N2C(N=C(C(F)=C2)N)=O)O1)O)O
Inchi : InChI=1S/C15H22FN3O6/c1-3-4-5-6-24-15(23)18-12-9(16)7-19(14(22)17-12)13-11(21)10(20)8(2)25-13/h7-8,10-11,13,20-21H,3-6H2,1-2H3,(H,17,18,22,23)/t8-,10-,11-,13-/m1/s1
Synonym : Capecitabine USP related compound A

Design of experiments (DoE) - based enhanced quality by design approach to hydrolytic degradation kinetic study of capecitabine by eco-friendly stability indicating UV-visible spectrophotometry

By Prajapati, Pintu; Patel, Radhika; Patel, Dilan; Shah, ShaileshnFrom American Journal of PharmTech Research (2020), 10(6), 115-133

Validated stability indicating HPLC method for estimation of capecitabine

By Lalitha, K. V.; Raveendra Reddy, J.; Devanna, N. – From International Journal of Pharmaceutical Sciences and Research (2020), 11(11), 5651-5658

RP-HPLC method development and validation for the simultaneous estimation of Irinotecan hydrochloride and Capecitabine in Active Pharmaceutical Ingredients (APIs)

By Vijaya Jyothi, M.; Bhargav, E.; Keerthana, B.; Varalakshmi, Devi K. – From International Journal of Research in Pharmaceutical Sciences (Madurai, India) (2018), 9(1), 63-67

Request For Quotation

Related Products